Page last updated: 2024-08-24

atorvastatin and Peripheral Nerve Diseases

atorvastatin has been researched along with Peripheral Nerve Diseases in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (20.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (40.00)	24.3611
2020's	2 (40.00)	2.80

Authors

Authors	Studies
Copkiran, Ö; Özdemir, IH; Tıkız, C; Tıkız, H	1
Al-Gareeb, AI; Al-Kuraishy, HM; Al-Naimi, MS; Hussien, NR; Rasheed, HA	1
Hammer, HS; Khalaf, S; Kroetz, DL; Mortensen, C; Nielsen, F; Poetz, O; Rodriguez-Antona, C; Stage, TB; Steffensen, V; Svenningsen, ÅF; Xiong, C	1
Gupta, LK; Gurha, N; Rehan, HS; Yadav, M	1
Wehmeier, T; Ziajka, PE	1

Reviews

2 review(s) available for atorvastatin and Peripheral Nerve Diseases

Article	Year
Statins an oft-prescribed drug is implicated in peripheral neuropathy: The time to know more. JPMA. The Journal of the Pakistan Medical Association, 2019, Volume: 69(Suppl 3), Issue:8 Topics: Atorvastatin; Drug Interactions; Dyslipidemias; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Peripheral Nervous System Diseases; Risk Factors; Simvastatin	2019
Peripheral neuropathy and lipid-lowering therapy. Southern medical journal, 1998, Volume: 91, Issue:7 Topics: Anticholesteremic Agents; Arteriosclerosis; Atorvastatin; Drug Therapy, Combination; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Male; Middle Aged; Naphthalenes; Niacin; Peripheral Nervous System Diseases; Pravastatin; Pyrroles; Simvastatin	1998

Other Studies

3 other study(ies) available for atorvastatin and Peripheral Nerve Diseases

Article	Year
Peripheral polyneuropathy in patients receiving long-term statin therapy. Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir, 2019, Volume: 47, Issue:7 Topics: Atorvastatin; Case-Control Studies; Drug Administration Schedule; Electromyography; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Incidence; Male; Middle Aged; Peripheral Nervous System Diseases; Risk Factors; Rosuvastatin Calcium; Turkey	2019
P-Glycoprotein Inhibition Exacerbates Paclitaxel Neurotoxicity in Neurons and Patients With Cancer. Clinical pharmacology and therapeutics, 2020, Volume: 108, Issue:3 Topics: Antineoplastic Agents, Phytogenic; Atorvastatin; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Cyclosporins; Dose-Response Relationship, Drug; Drug Interactions; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Neurons; Paclitaxel; Peripheral Nervous System Diseases; Retrospective Studies; Risk Assessment; Risk Factors; Simvastatin; Verapamil	2020
Association of statin induced reduction in serum coenzyme Q10 level and conduction deficits in motor and sensory nerves: An observational cross-sectional study. Clinical neurology and neurosurgery, 2020, Volume: 196 Topics: Atorvastatin; Cross-Sectional Studies; Dyslipidemias; Female; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Neural Conduction; Peripheral Nervous System Diseases; Rosuvastatin Calcium; Ubiquinone	2020